33754 results about "Ethylene glycol" patented technology

The present invention provides a dissolvable medical sealing device (3, 4; 6, 7; 9) for closing a wound in vessel. A sealing device (3, 4, 6, 7, 9) according to the invention is made of a material that dissolves by means of physical processes, rather than by means of chemical or biological processes. Such a sealing device (3, 4; 6, 7; 9) can be made of polyethylene glycol, polypropylene glycol, copolymers containing ethylene glycol and propylene glycol, polyvinyl alcohol or polyvinyl pyrolidone, or any combinations thereof.

Methods for forming nanostructures of various shapes are disclosed. Nanocubes, nanowires, nanopyramids and multiply twinned particles of silver may by formed by combining a solution of silver nitrate in ethylene glycol with a solution of poly(vinyl pyrrolidone) in ethylene glycol. Hollow nanostructures may be formed by reacting a solution of solid nanostructures comprising one of a first metal and a first metal alloy with a metal salt that can be reduced by the first metal or first metal alloy. Nanostructures comprising a core with at least one nanoshell may be formed by plating a nanostructure and reacting the plating with a metal salt.

The present invention relates to a peptide-based compound comprising a peptide moiety and a poly(ethylene glycol) moiety wherein the poly(ethylene glycol) moiety (preferably linear) has a molecular weight of more than 20 KDaltons (preferably from 20 to 60 KDaltons). The peptide moiety may be monomeric, dimeric or oligomeric. Such peptide-based compounds may optional include a linker moiety and / or a spacer moiety.

The invention relates to stable pharmaceutical or cosmetic foam compositions containing certain active agents, having unique therapeutic properties and methods of treatment using such compositions. The foamable composition includes at least one solvent comprising polyethylene glycol (PEG) or PEG derivative and mixtures thereof, or comprising propylene glycol, wherein the solvent is present at a concentration of about 70% to about 96.5% by weight of the total composition, at least a non-ionic surface-active agent at a concentration of about 0.1% to less than about 10% by weight of the total composition.

A sheet made of a polyester which includes monomer units of terephthaloyl moieties, ethylene glycol moieties and isosorbide moieties is described. The polyester has an inherent viscosity of at least about 0.35 dL / g when measured as a 1% (weight / volume) solution of said polyester in o-chlorophenol at a temperature of 25 DEG C. The present invention also relates to a method of making the polyester sheet described above and a method of thermoforming the sheet into articles.

Conjugates of a Factor VIII moiety and one or more water-soluble polymers are provided. Typically, the water-soluble polymer is poly(ethylene glycol) or a derivative thereof. Also provided are compositions comprising the conjugates, methods of making the conjugates, and methods of administering compositions comprising the conjugates to a patient.

The present invention generally relates to reducing the mucoadhesive properties of a particle. In some embodiments, the particle is coated with and / or associated with a (poly(ethylene glycol))-(poly(propylene oxide))-(poly(ethylene glycol)) triblock copolymer. Methods for preparing inventive particles using a poly(ethylene glycol)-vitamin E conjugate as a surfactant are also provided. In some embodiments, methods are provided comprising administering to a subject a composition of particles of the present invention. Such particles with reduced mucoadhesive properties are useful in delivering agents to mucosal tissues such as oral, ophthalmic, gastrointestinal, nasal, respiratory, and genital mucosal tissues.

The present invention provides a decorative floor covering comprising a surface layer and a substrate layer underneath, wherein the surface layer comprises a polyethylene terephthalate film layer, and a method for preparing the same. Furthermore, the present invention provides a decorative floor covering comprising a surface layer and a substrate layer underneath, wherein a light weight back layer is further comprised under the substrate layer, and a method for preparing the same. A decorative floor covering of the present invention is a decorative floor covering which has superior surface heat resistance, printing sharpness and realism, and it can be installed conveniently since not only can non-foamed polyvinyl chloride resin be used as a substrate layer, but also the weight of a floor covering is light when a light weight back layer is comprised under the substrate layer.

Conjugates of an IL-2 moiety and one or more nonpeptidic, water-soluble polymers are provided. Typically, the nonpeptidic, water-soluble polymer is poly(ethylene glycol) or a derivative thereof. Also provided, among other things, are compositions comprising conjugates, methods of making conjugates, methods of administering compositions to an individual, nucleic acid sequences, expression systems, host cells, and methods for preparing IL-moieties.

An optical article made of a transparent polymer which includes terephthaloyl moieties, optionally, other aromatic diacid moieties; ethylene glycol moieties; isosorbide moieties; and, optionally, one or more other diol moieties, wherein the polymer has an inherent viscosity of at least about 0.35 dL / g as measured on a 1% solution (weight / volume) in o-chlorophenol at 25 DEG C.

A novel fluid heat transfer agent suitable for use in a closed heat transfer system, for example, wherein energy is transferred between an evaporator and a condenser in heat exchange relationship with the heat transfer agent that is caused to flow from one to the other. The novel heat transfer agent is a complex comprising a body of heat transfer fluid, for example, ethylene glycol or water, having suspended therein carbon nanoparticles in a quantity sufficient to enhance the thermal conductivity of the body of heat transfers fluid, per se. The carbon nanoparticles are selected from carbon in the form of sp<2 >type and sp<3 >type bonding and preferably comprise nanotubes or fullerenes and may have a coupling agent bonded thereto or enclosed therein when the nanotube or fullerene forms a hollow capsule. The coupling agent may be a polar organic group covalently bonded to the carbon nanoparticles and miscible in the fluid medium.

A catalyst for hydrogenated synthesis of glycol with oxalate and a preparation method for the catalyst belong to the glycol preparation technical field. The catalyst of the present invention uses the copper metal as the main active component, and zinc as the promoter, and is manufactured with the method of deposition. A carrier of the catalyst is the modified silica sol. The select content of the copper metal is 5 to 45 percent of the carrier weight, and the optimal content of the copper metal is 10 to 40 percent. The content of zinc metal is 0.1 to 15 percent of the carrier weight, and the optimal content of zinc metal is 1 to 8.0 percent. The select specific surface area of the carrier is 90-350m2 / g, and the optimal is 150-300m2 / g. Proven by experiments, the catalyst is provided with the very high reaction activity and glycollate selectivity in the reaction to synthesize glycollate with oxalate and hydrogen Moreover, the catalyst is provided with the long usable life and the stable reaction performance, and can be easily controlled.

Compositions, methods, and applications that increase the efficiency of nucleic acid transfection are provided. In one aspect, a pharmaceutical composition may include at least about 0.5 mg / ml concentration of a nucleic acid condensed with a cationic lipopolymer suspended in an isotonic solution, where the cationic lipopolymer includes a cationic polymer backbone having cholesterol and polyethylene glycol covalently attached thereto, and wherein the molar ratio of cholesterol to cationic polymer backbone is within a range of from about 0.1 to about 10, and the molar ratio of polyethylene glycol to cationic polymer backbone is within a range of from about 0.1 to about 10. The composition further may include a filler excipient.

An electrode providing electrical contact with a patient's skin includes a conductive member adapted for connection to an external electrical apparatus and a non-liquid water containing film for electrically interfacing to said patient's skin, the non-liquid film being electrically and mechanically connected to said conductive member. The non-liquid water containing film includes an electrically conductive organic polymer plasticized with a polyhydric alcohol with said organic polymer being derived from a monomeric mixture comprising from about 2 to 30 pph acrylic acid, 2 to 30 pph of a glycolvinylether and 0.01 to 1.5 pph of a crosslinking agent. Preferably the polyhydric alcohol is glycerol.

3,4-Dihydroxyphenyl-L-alanine (DOPA) is an unusual amino acid found in mussel adhesive proteins (MAPs) that form tenacious bonds to various substrates under water. DOPA is believed to be responsible for the adhesive characteristics of MAPs. This invention relates to a route for the conjugation of DOPA moieties to various polymeric systems, including but not limited to poly(ethylene glycol) or poly(alkylene oxide) systems such as poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) block copolymers.

A radiolabeling method using a multivalent glycoligand as hepatic receptor imaging agent is provided. The multivalent glycoligand-DTPA derivatives (In-111-DTPA-hexa lactoside and In-111-DTPA-tri-galactosamine glycoside) labeled with In-111 are used as hepatic receptor imaging agent. The effects of imaging of a hepatic receptor in different species are evaluated, the lowest specific radioactivity values of hepatic receptor imaging required in different species are discovered. Since the specificity of the human ASGPR closely resembles that of the mouse. This kind of radiolabelling method, agent and related study about specific radioactivity could be used in clinical trial in the future.

The invention relates to a continuous reaction process flow for producing ethylene glycol and 1, 2-propylene glycol through continuous hydrocrackin of sugars and provides a method for producing the ethylene glycol and the 1,2-propylene glycol through continuous hydrocrackin of sugars. In the process flow, sugars (comprising one or more than two of sugar, glucose, fructose, xylose, soluble xylo-oligosaccharide and starch) are hydrocracked in the presence of a catalyst in a reactor and the hydrocracked product enters a separating system. Hydrogen gas in a gas phase is recycled by separating and recovering; a liquid phase product partially reflows to the reactor and other liquid phase products are refined and separated to form the ethylene glycol, the propylene glycol and other polyhydric alcohols; and concentrated soluble catalyst components in the refined and separated residual component liquid phase are partially returned to the reactor.

The present invention provides cationic-polymer-lipid conjugates (CPLs) such as distal cationic-poly(ethylene glycol)-lipid conjugates which can be incorporated into conventional and stealth liposomes or other lipid-based formulation for enhancing cellular uptake. The CPLs of the present invention comprise a lipid moiety; a hydrophilic polymer; and a polycationic moiety. Method of increasing intracellular delivery of nucleic acids are also provided.

The invention relates to a system for comprehensively utilizing LNG cold energy for power generation and cold supply. The system comprises a LNG supercharging gasification direct expansion power generation system, a mixed working medium Rankine cycle power generation system, a liquid ammonia refrigeration house cold supply system and an ethylene glycol ice storage bath air conditioner cold supplycirculation system. The cold energy released in the LNG gasification process is utilized; high-grade electric energy is generated through LNG supercharging gasification direct expansion power generation and mixed working medium Rankine cycle power generation; cold is supplied to a refrigeration house through the cold energy released in the LNG gasification process for ammonia recycling; and cold is supplied to an air conditioner through the cold energy released in the LNG gasification process for ethylene glycol ice storage bath recycling. By means of the system, gradient utilization of the LNG cold energy is achieved, and the cold energy utilization efficiency is high.

A mixture of a polyester, such as poly(ethylene terephthalate) PET, or a polyamide, and a suitable stabilizer selected from the group consisting of hydroxylamine stabilizers, substituted hydroxylamine stabilizers, nitrone stabilizers and amine oxide stabilizers, when extrusion compounded exhibits a lower residual acetaldehyde content than does polyester or polyamide alone when similarly treated. The invention pertains to any polyester or polyamide used in the manufacture of molded articles, fibers or films, for instance bottles or containers which are used to store consumer materials, for example food, beverages and water.

The invention relates to a system for comprehensively utilizing LNG cold energy for power generation and cold supply. The system comprises a LNG supercharging gasification direct expansion power generation system, a mixed working medium Rankine cycle power generation system, a liquid ammonia refrigeration house cold supply system and an ethylene glycol ice storage bath air conditioner cold supplycirculation system. The cold energy released in the LNG gasification process is utilized; high-grade electric energy is generated through LNG supercharging gasification direct expansion power generation and mixed working medium Rankine cycle power generation; cold is supplied to a refrigeration house through the cold energy released in the LNG gasification process for ammonia recycling; and cold is supplied to an air conditioner through the cold energy released in the LNG gasification process for ethylene glycol ice storage bath recycling. By means of the system, gradient utilization of the LNG cold energy is achieved, and the cold energy utilization efficiency is high.

The present invention is directed to branched reactive water-soluble polymers comprising at least two polymer arms, such as poly(ethylene glycol), attached to a central aliphatic hydrocarbon core molecule through heteroatom linkages. The branched polymers bear at least one functional group for reacting with a biologically active agent to form a biologically active conjugate. The functional group of the branched polymer can be directly attached to the aliphatic hydrocarbon core or via an intervening linkage, such as a heteroatom, -alkylene-, —O-alkylene-O—, -alkylene-O-alkylene-, -aryl-O—, —O-aryl-, (—O-alkylene-)m, or (-alkylene-O—)m linkage, wherein m is 1–10.

A powdered tocopheryl polyethylene glycol succinate (TPGS™) having an average particle size of less than about 1000 microns. In one embodiment, the powdered tocopheryl polyethylene glycol succinate is prepared by a process that includes atomizing a fluidic tocopheryl polyethylene glycol succinate into an environment suitable for solidifying the atomized tocopheryl polyethylene glycol succinate. In another embodiment, the powdered tocopheryl polyethylene glycol succinate is prepared by a process of applying a force to a solid tocopheryl polyethylene glycol succinate starting material that is sufficient to produce a powdered product.

In a process for converting lingnocellulosic biomass to ethanol, the improvement of obtaining higher fermentable soluble sugar yields by drying acid impregnated biomass particles, comprising: a) feeding moist lignocellulosic biomass into an acid impregnator to render it acid-soaked and draining the acid-soaked biomass to about 30% to 35% by weight solids; b) dewatering the acid-soaked biomass by drying or centrifugation to prevent compaction of the biomass and arrive at about 40% to 60% by weight solids; c) subjecting the acid-impregnated biomass to a first-stage hydrolysis reactor at a temperature of from 130° C. to 220° C. and discharging formed hydrolysate into a flash tank at about 120° C. to 140° C. to hydrolyze most of the remaining soluble oligosaccharides to monomeric sugars, and flashing remaining hydrolysate to a second flash tank at a lower temperature than the first flash tank-the second flash tank serving as a feed surge tank for a counter-current extractor; d) washing the hydrolysate, adjusting the pH of the sugar extract to about 5, and recovering more than 95% of the soluble sugars in the first-stage hydrolysate slurry by a counter-current extractor; e) subjecting remaining washed-first stage solids of pretreated biomass to a second-stage acid and metal salt impregnator and dewatering by drying or centrifugation to prevent compaction of biomass to arrive at 40% to 60% by weight solids; f) subjecting the acid and metal salt-impregnated biomass to a second-stage hydrolysis reactor at a temperature from 190° C. to 240° C. and discharging formed hydrolysate into a flash tank, at about 120° C. to 140° C. to hydrolyze most of the remaining soluble oligosaccharides to monomeric sugars and flashing remaining hydrolysate to a second flash tank at a lower temperature than the first flash tank, the second flash tank serving as a feed surge tank for second-stage fementors; g) cooling pH-adjusted extract from the counter-current extractor, feeding the extract to a first-stage fermentor and air sparging the first-stage fermentor at a rate sufficient to promote enough yeast growth to compensate for loss through second-stage fermentors; h) pH adjusting second-stage hydrolysate slurry to 4.5, cooling the slurry and adding it into the top of the first fermentor of a two-fermentor train in the second stage fermentors, pumping broth from the bottom of the first stage fermentors to the second stage fermentors while the yeast is in the growth phase for a period sufficient to consume over 95% of fermentable sugars; and i) recovering ethanol.

The present invention relates to traditional Chinese medicine for treating coronary heart disease and stenocardia is made from (by wt.%) salvia root 50-97%, notoginseng 2-48% and borneol 0.2-3%, in which the salvia root and notoginseng and hot extracted with water, then filtering, concentrating, alcohol precipitating, standing still, recovering ethyl alcohol, concentrating, into extractum, further blended with borneol and adjuvant polyglycol-6000 to form into product.

The present invention generally relates to reducing the mucoadhesive properties of a particle. In some embodiments, the particle is coated with and / or associated with a (poly(ethylene glycol))-(poly(propylene oxide))-(poly(ethylene glycol)) triblock copolymer. Methods for preparing inventive particles using a poly(ethylene glycol)-vitamin E conjugate as a surfactant are also provided. In some embodiments, methods are provided comprising administering to a subject a composition of particles of the present invention. Such particles with reduced mucoadhesive properties are useful in delivering agents to mucosal tissues such as oral, ophthalmic, gastrointestinal, nasal, respiratory, and genital mucosal tissues.